Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.81 |
| ▸ | TSHR | P16473 | 3/20 | 0.81 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.81 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexadecylamine SCHEMBL15008626 | 1.00 | DNM1 (0.81) | DNM1TSHREPHX1MEN1KMT2A | |
| Tetradecylamine SCHEMBL27575417 | 1.00 | DNM1 (0.81) | DNM1TSHREPHX1MEN1KMT2A | |
| Dodecylamine SCHEMBL21795737 | 1.00 | DNM1 (0.81) | DNM1TSHREPHX1MEN1KMT2A | |
| Dimethylamine SCHEMBL3910442 | 1.00 | DNM1 (0.81) | DNM1TSHREPHX1MEN1KMT2A | |
| Decylamine SCHEMBL28332306 | 0.97 | DNM1 (0.82) | DNM1TSHREPHX1MEN1KMT2A | |
| Dimethylamine SCHEMBL28185149 | 0.97 | DNM1 (0.82) | DNM1TSHREPHX1MEN1KMT2A | |
| Dodecylamine SCHEMBL28207326 | 0.97 | DNM1 (0.82) | DNM1TSHREPHX1MEN1KMT2A | |
| Octadecylamine SCHEMBL28856395 | 0.97 | DNM1 (0.82) | DNM1TSHREPHX1MEN1KMT2A | |
| Hexadecylamine SCHEMBL28097759 | 0.97 | DNM1 (0.82) | DNM1TSHREPHX1MEN1KMT2A | |
| Dimethylamine SCHEMBL2153560 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112110484-A | Amorphous TiO for lithium battery2Ultraviolet light induced crystallization preparation method of hydrolysis ball | 华北电力大学 | 2020-12-22 | — | — | CN | disclosed |
| CN-109715775-A | Liquid detergent | 狮王株式会社 | 2019-05-03 | — | — | CN | disclosed |
| US-7615102-B2 | Corrosion and gas hydrate inhibitors with an increased biological degradability and a reduced toxicity | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-11-10 | — | — | US | disclosed |
| US-20090173663-A1 | Corrosion and gas hydrate inhibitors with an increased biological degradability and a reduced toxicity | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-07-09 | — | — | US | disclosed |
| US-7435845-B2 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-10-14 | — | — | US | disclosed |
| US-7348451-B2 | Additives for inhibiting gas hydrate formation | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-03-25 | — | — | US | disclosed |
| US-7341617-B2 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-03-11 | — | — | US | disclosed |
| US-7323609-B2 | quaternary amonium compound; not only slow the formation of gas hydrates (kinetic inhibitors) but also keep agglomerates small and pumpable (antiagglomerates) reduced | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-01-29 | — | — | US | disclosed |
| US-7253138-B2 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2007-08-07 | — | — | US | disclosed |
| US-20070173672-A1 | Additives for inhibiting gas hydrate formation | CLARIANT GMBH | 2007-07-26 | — | — | US | disclosed |
| US-7214814-B2 | Additives for inhibiting gas hydrate formation | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2007-05-08 | — | — | US | disclosed |
| US-20050101495-A1 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT GMBH | 2005-05-12 | — | — | US | disclosed |
| US-20040167040-A1 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT GMBH | 2004-08-26 | — | — | US | disclosed |
| US-20040163307-A1 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT GMBH | 2004-08-26 | — | — | US | disclosed |
| US-20040163306-A1 | Additives for inhibiting gas hydrate formation | CLARIANT GMBH | 2004-08-26 | — | — | US | disclosed |
| US-20040164278-A1 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CLARIANT GMBH | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173672-A1 | Additives for inhibiting gas hydrate formation | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHRM5, CHRM2 | DNM1 3762/4885TSHR 1737/4885EPHX1 1992/4885 |
| US-20040167040-A1 | Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability | CA3, CA7, CA1 | DNM1 2979/4885TSHR 3918/4885EPHX1 748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.